Production of cloned bovine fetuses following nuclear transfer using cells from a fetal fibroblast cell line

1998 ◽  
Vol 49 (1) ◽  
pp. 330 ◽  
Author(s):  
D.N. Wells ◽  
P.M. Misica ◽  
W.H. McMillan ◽  
H.R. Tervit
2003 ◽  
Vol 36 (11) ◽  
pp. 1485-1489 ◽  
Author(s):  
M.R.B. Mello ◽  
H.V.A. Caetano ◽  
M.G. Marques ◽  
M.S. Padilha ◽  
J.F. Garcia ◽  
...  

2004 ◽  
Vol 16 (2) ◽  
pp. 160 ◽  
Author(s):  
D.K. Vanderwall ◽  
G.L. Woods ◽  
K.I. Aston ◽  
T.D. Bunch ◽  
G.-P. Li ◽  
...  

We recently reported the birth of the first clone of an equine species, a mule, which was produced using a fetal fibroblast cell line (Woods GL et al., 2003 Science 301, 1063). Since the birth of the first foal, two more identical cloned mule foals have been born. All three foals were delivered spontaneously without assistance, and have been healthy and vigorous since birth. Even more recently, the birth of a horse foal cloned from an adult fibroblast cell line was reported (Touchette N, 2003 Nature 424, 635). Despite these successes, the efficiency of equine nuclear transfer (NT) continues to be very low. The objective of this study was to use NT to clone adult horses using cumulus cells. Cumulus-oocyte complexes used for NT were obtained using transvaginal ultrasound-guided follicle aspiration (TVA) 24hrs after hCG treatment; oocytes were used as cytoplasts, while cumulus cells (from one of three different mares) were used as donor cells. Cumulus cells were recovered from TVA fluid, washed two times by suspension in PB1 medium (Whittingham DG, 1974 J. Reprod. Fertil. 37, 159–162), followed by centrifugation (200g) and placement in Glasgow MEM BHK-21 containing 10% FBS. Nuclear transfer procedures were performed as described (Woods GL et al., 2003 Science 301, 1063). Immediately following NT and activation procedures, cloned embryos were surgically transferred to the oviduct of recipient mares (n=2 to 5 embryos/recipient) that had ovulated within 24hrs prior to the transfer. An initial pregnancy examination was performed between Days 14 and 16 (Day 0=surgery); subsequent examinations were then performed at approximately weekly intervals. A total of 136 follicles were aspirated in 96 mares, from which 72 oocytes were recovered (53%). Sixty-two cloned embryos were subsequently transferred to recipient mares, which resulted in 7 (11.3%) ultrasonographically-detectable pregnancies. Cumulus cells from Mare 160 tended (P=0.08) to result in more pregnancies than cumulus cells from Mare 221 (4/17 v. 1/25, respectively). All seven cloned pregnancies underwent spontaneous pregnancy loss between Days 16 and 80. An embryo-proper and heartbeat were detected in three conceptuses. Of four conceptuses in which an embryo-proper was not observed, three did not develop past Day 24; therefore, they were lost before the time at which an embryo-proper generally becomes readily apparent. One conceptus developed to Day 28, yet still failed to form an embryo-proper. There were no premonitory signs of impending embryonic loss in the conceptuses that did not develop an embryo-proper; the conceptus was simply not evident at the subsequent examination. Signs of impending embryonic loss were observed in the three conceptuses in which an embryo-proper was observed, and included: (1) loss of embryonic heartbeat, (2) disorganization of the conceptus membranes, and (3) increased echogenicity of conceptus fluids. One or more of these signs were observed in all three conceptuses prior to pregnancy loss. To our knowledge, this is the first report documenting the establishment of cloned horse pregnancies produced using adult cumulus cells.


2018 ◽  
Vol 30 (1) ◽  
pp. 157
Author(s):  
M. Nõmm ◽  
M. Ivask ◽  
P. Pärn ◽  
Ü. Jaakma ◽  
S. Kõks

Somatic cell nuclear transfer (SCNT) is, to date, the most used technology producing transgenic (TG) cattle. Depending on the gene construct and transfection method, transfection efficiency may differ greatly. Applying a more intense selection regime after transfection may obliterate the cells. An extended selection affects the passage number and leads to genotypic and phenotypic drift of the cells. We used the pBC1 Milk Expression Vector Kit (cat. no. K270-01, Invitrogen Corp., Carlsbad, CA, USA) to make the expression vector of human FSH (hFSH). For TG fibroblast cell line, the AmaxaTM NucleofectorTM Kit for Primary Fibroblasts (cat. no. VPI-1002, Lonza Grouop, Basel, Switzerland) was used. For TG fibroblast selection, G418 (neomycin) was used for 21 days with a final concentration of 400 µg mL−1. The final passage number of the cell line was 6. The primers included in the pBC1 Milk Expression Vector Kit-BCF (GATTGACAAGTAATACGCTGTTTCCTC) and BCR (CATCAGAAGTTAAACAGCACAGTTAG)-were used to control the insert. The transgenesis of the cell line was confirmed by sequencing the PCR product and analysing it with the BlastN and Bioedit software to make sure the fibroblast cell line was hFSH-positive. These cells were thereafter randomly used for SCNT as donor cells. All the SCNT embryos were cultured for 4 days in IVF Bioscience (Falmouth, United Kingdom) culture media and then biopsied. After aspirating 1 blastomere from the 6- to 8-cell-stage embryo, the biopsied embryos were further individually cultured until Day 7 and blastocyst formation was recorded. Genomic DNA from the biopsies was isolated and amplified with REPLI-g Single Cell Kit (Qiagen, Valencia, CA, USA) according to the manufacturer’s protocol. The primers BCF and BCR were used to control the hFSH positivity of the embryos, and the PCR product was visualised on a 1% agarose gel. From 62 biopsied SCNT cloned embryos, 22 (35.48%) tested TG positive. The total blastocyst yield from biopsied embryos was 26 (41.93%), of which 12 (54.54%) were TG positive blastocysts and selected for transfer. Our hFSH TG fibroblast cell line demonstrated a low concentration of TG cells in its culture, despite the selection and verification methods applied. Based on the analysis of SCNT embryos, only 54.54% of the embryos developed were TG positive. The embryo biopsying technique enables us to use only TG-positive SCNT cloned embryos for transfer, therefore avoiding non-TG pregnancies. This study was supported by Enterprise Estonia grant EU30020, Institutional research funding IUT 8-1 and Horizon 2020 Project SEARMET 692299.


2006 ◽  
Vol 192 (7) ◽  
pp. 743-751 ◽  
Author(s):  
Barbara A. Murphy ◽  
Mandi M. Vick ◽  
Dawn R. Sessions ◽  
R. Frank Cook ◽  
Barry P. Fitzgerald

Biologia ◽  
2008 ◽  
Vol 63 (2) ◽  
Author(s):  
Marica Theiszová ◽  
Soňa Jantová ◽  
Silvia Letašiová ◽  
Ľuboš Valík ◽  
Martin Palou

AbstractThe number of biomaterials used in biomedical applications has rapidly increased in the past two decades. Fluorapatite (FA) is one of the inorganic constituents of bone or teeth used for hard tissue repairs and replacements. Fluor-hydroxyapatite (FHA) is a new synthetically prepared composite that in its structure contains the same molecular concentration of OH− groups and F− ions. The aim of this experimental investigation was to use the embryonal mouse fibroblast cell line NIH-3T3 for comparative study of basal cytotoxicity of fluoridated biomaterials FHA and FA discs. Hydroxyapatite (HA) disc, high-density polyethylene as negative control and polyvinyl chloride (PVC) containing organotin stabilizer as positive control were used as standard biomaterials. The appropriateness of the use of NIH-3T3 cells and their sensitivity for tested biomaterials were evaluated on the basis of five cytotoxic end points: cell proliferation, cell morphology, lactate dehydrogenase (LDH) released, protein and DNA cell content. The basal cytotoxicity of FHA, FA and HA discs was measured by direct contact method. FHA composite, FA and HA demonstrated in cell line NIH-3T3 nearly similar basal cytotoxicity increasing with the time of treatment. After 72 h of biomaterials treatment, about 25% inhibition of cell number, unchanged morphology of dividing cells, 6.31–0.16% increase of released LDH, about 10% inhibition of cell protein content and about 20% inhibition of DNA content was found. On the other hand, from the growth rates it resulted that NIH-3T3 cells, affected by tested biomaterials, divided about 20% slowlier than the control (untreated cells). Using the linear regression analysis we found out that deviations in measurements of cytotoxicity by four methods were as follows: less than 10% for cell number, protein and DNA content methods and 12.4% for released LDH method. Based on a good correlation of the cytotoxicity of biomaterials obtained from all end points we could conclude that fibroblast NIH-3T3 cell line was appropriate for measuring the basal cytoxicity of tested biomaterials.


Sign in / Sign up

Export Citation Format

Share Document